decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

n/a Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.

  1. Home
  2. About Grants
  3. Regulatory Considerations For Using Pharmaceutical Products In Research Involving Laboratory Animals - June 4, 2015

Regulatory Considerations for Using Pharmaceutical Products in Research Involving Laboratory Animals - June 4, 2015

Audience: The program is tailored to IACUC staff, IACUC members, IOs, veterinarians, investigators, compliance personnel, animal care staff and others involved in animal programs. 

Speakers:

  • Dorothy Bailey, DVM, Program Head, Index of Legally Marketed Unapproved New Animal Drugs for Minor Species, Center for Veterinary Medicine, FDA
  • Neal Bataller, ME, DVM, Division of Surveillance, Center for Veterinary Medicine, FDA

Topics: Dr. Bailey discusses the legal options for use of drugs in laboratory research animals. These include new animal drug approval, conditional approval, investigational use, and indexing. Dr. Bataller discusses the regulatory status of drugs, including the extralabel use of approved drugs, compounding from bulk drugs, and other illegal manufacturing.

Supporting materials
Transcript (PDF) -
Slides (PDF) -
Questions
Submit comments or questions here or send email to OLAW at olawdpe@mail.nih.gov.

This page last updated on: April 25, 2024

Technical Issues: E-mail OER Webmaster